294 related articles for article (PubMed ID: 24030424)
1. Sustained release of engineered stromal cell-derived factor 1-α from injectable hydrogels effectively recruits endothelial progenitor cells and preserves ventricular function after myocardial infarction.
MacArthur JW; Purcell BP; Shudo Y; Cohen JE; Fairman A; Trubelja A; Patel J; Hsiao P; Yang E; Lloyd K; Hiesinger W; Atluri P; Burdick JA; Woo YJ
Circulation; 2013 Sep; 128(11 Suppl 1):S79-86. PubMed ID: 24030424
[TBL] [Abstract][Full Text] [Related]
2. Spliced stromal cell-derived factor-1α analog stimulates endothelial progenitor cell migration and improves cardiac function in a dose-dependent manner after myocardial infarction.
Hiesinger W; Frederick JR; Atluri P; McCormick RC; Marotta N; Muenzer JR; Woo YJ
J Thorac Cardiovasc Surg; 2010 Nov; 140(5):1174-80. PubMed ID: 20951261
[TBL] [Abstract][Full Text] [Related]
3. Preclinical evaluation of the engineered stem cell chemokine stromal cell-derived factor 1α analog in a translational ovine myocardial infarction model.
Macarthur JW; Cohen JE; McGarvey JR; Shudo Y; Patel JB; Trubelja A; Fairman AS; Edwards BB; Hung G; Hiesinger W; Goldstone AB; Atluri P; Wilensky RL; Pilla JJ; Gorman JH; Gorman RC; Woo YJ
Circ Res; 2014 Feb; 114(4):650-9. PubMed ID: 24366171
[TBL] [Abstract][Full Text] [Related]
4. Computational protein design to reengineer stromal cell-derived factor-1α generates an effective and translatable angiogenic polypeptide analog.
Hiesinger W; Perez-Aguilar JM; Atluri P; Marotta NA; Frederick JR; Fitzpatrick JR; McCormick RC; Muenzer JR; Yang EC; Levit RD; Yuan LJ; Macarthur JW; Saven JG; Woo YJ
Circulation; 2011 Sep; 124(11 Suppl):S18-26. PubMed ID: 21911811
[TBL] [Abstract][Full Text] [Related]
5. Tissue-engineered, hydrogel-based endothelial progenitor cell therapy robustly revascularizes ischemic myocardium and preserves ventricular function.
Atluri P; Miller JS; Emery RJ; Hung G; Trubelja A; Cohen JE; Lloyd K; Han J; Gaffey AC; MacArthur JW; Chen CS; Woo YJ
J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1090-7; discussion 1097-8. PubMed ID: 25129603
[TBL] [Abstract][Full Text] [Related]
6. Delivery of progenitor cells with injectable shear-thinning hydrogel maintains geometry and normalizes strain to stabilize cardiac function after ischemia.
Gaffey AC; Chen MH; Trubelja A; Venkataraman CM; Chen CW; Chung JJ; Schultz S; Sehgal CM; Burdick JA; Atluri P
J Thorac Cardiovasc Surg; 2019 Apr; 157(4):1479-1490. PubMed ID: 30579534
[TBL] [Abstract][Full Text] [Related]
7. Mathematically engineered stromal cell-derived factor-1α stem cell cytokine analog enhances mechanical properties of infarcted myocardium.
MacArthur JW; Trubelja A; Shudo Y; Hsiao P; Fairman AS; Yang E; Hiesinger W; Sarver JJ; Atluri P; Woo YJ
J Thorac Cardiovasc Surg; 2013 Jan; 145(1):278-84. PubMed ID: 23244259
[TBL] [Abstract][Full Text] [Related]
8. Stromal cell-derived factor-1alpha activation of tissue-engineered endothelial progenitor cell matrix enhances ventricular function after myocardial infarction by inducing neovasculogenesis.
Frederick JR; Fitzpatrick JR; McCormick RC; Harris DA; Kim AY; Muenzer JR; Marotta N; Smith MJ; Cohen JE; Hiesinger W; Atluri P; Woo YJ
Circulation; 2010 Sep; 122(11 Suppl):S107-17. PubMed ID: 20837901
[TBL] [Abstract][Full Text] [Related]
9. Bioengineered analog of stromal cell-derived factor 1α preserves the biaxial mechanical properties of native myocardium after infarction.
Wang H; Wisneski A; Paulsen MJ; Imbrie-Moore A; Wang Z; Xuan Y; Hernandez HL; Lucian HJ; Eskandari A; Thakore AD; Farry JM; Hironaka CE; von Bornstaedt D; Steele AN; Stapleton LM; Williams KM; Wu MA; MacArthur JW; Woo YJ
J Mech Behav Biomed Mater; 2019 Aug; 96():165-171. PubMed ID: 31035067
[TBL] [Abstract][Full Text] [Related]
10. Injectable shear-thinning hydrogels used to deliver endothelial progenitor cells, enhance cell engraftment, and improve ischemic myocardium.
Gaffey AC; Chen MH; Venkataraman CM; Trubelja A; Rodell CB; Dinh PV; Hung G; MacArthur JW; Soopan RV; Burdick JA; Atluri P
J Thorac Cardiovasc Surg; 2015 Nov; 150(5):1268-76. PubMed ID: 26293548
[TBL] [Abstract][Full Text] [Related]
11. Sustained release of endothelial progenitor cell-derived extracellular vesicles from shear-thinning hydrogels improves angiogenesis and promotes function after myocardial infarction.
Chen CW; Wang LL; Zaman S; Gordon J; Arisi MF; Venkataraman CM; Chung JJ; Hung G; Gaffey AC; Spruce LA; Fazelinia H; Gorman RC; Seeholzer SH; Burdick JA; Atluri P
Cardiovasc Res; 2018 Jun; 114(7):1029-1040. PubMed ID: 29566124
[TBL] [Abstract][Full Text] [Related]
12. Injectable Shear-Thinning Hydrogels for Minimally Invasive Delivery to Infarcted Myocardium to Limit Left Ventricular Remodeling.
Rodell CB; Lee ME; Wang H; Takebayashi S; Takayama T; Kawamura T; Arkles JS; Dusaj NN; Dorsey SM; Witschey WR; Pilla JJ; Gorman JH; Wenk JF; Burdick JA; Gorman RC
Circ Cardiovasc Interv; 2016 Oct; 9(10):. PubMed ID: 27729419
[TBL] [Abstract][Full Text] [Related]
13. Rehmannia glutinosa extract activates endothelial progenitor cells in a rat model of myocardial infarction through a SDF-1 α/CXCR4 cascade.
Wang YB; Liu YF; Lu XT; Yan FF; Wang B; Bai WW; Zhao YX
PLoS One; 2013; 8(1):e54303. PubMed ID: 23349848
[TBL] [Abstract][Full Text] [Related]
14. Stromal cell-derived factor and granulocyte-monocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy.
Woo YJ; Grand TJ; Berry MF; Atluri P; Moise MA; Hsu VM; Cohen J; Fisher O; Burdick J; Taylor M; Zentko S; Liao G; Smith M; Kolakowski S; Jayasankar V; Gardner TJ; Sweeney HL
J Thorac Cardiovasc Surg; 2005 Aug; 130(2):321-9. PubMed ID: 16077394
[TBL] [Abstract][Full Text] [Related]
15. Multi-phase catheter-injectable hydrogel enables dual-stage protein-engineered cytokine release to mitigate adverse left ventricular remodeling following myocardial infarction in a small animal model and a large animal model.
Steele AN; Paulsen MJ; Wang H; Stapleton LM; Lucian HJ; Eskandari A; Hironaka CE; Farry JM; Baker SW; Thakore AD; Jaatinen KJ; Tada Y; Hollander MJ; Williams KM; Seymour AJ; Totherow KP; Yu AC; Cochran JR; Appel EA; Woo YJ
Cytokine; 2020 Mar; 127():154974. PubMed ID: 31978642
[TBL] [Abstract][Full Text] [Related]
16. A novel protein-engineered hepatocyte growth factor analog released via a shear-thinning injectable hydrogel enhances post-infarction ventricular function.
Steele AN; Cai L; Truong VN; Edwards BB; Goldstone AB; Eskandari A; Mitchell AC; Marquardt LM; Foster AA; Cochran JR; Heilshorn SC; Woo YJ
Biotechnol Bioeng; 2017 Oct; 114(10):2379-2389. PubMed ID: 28574594
[TBL] [Abstract][Full Text] [Related]
17. Bone-derived Nestin-positive mesenchymal stem cells improve cardiac function via recruiting cardiac endothelial cells after myocardial infarction.
Lu D; Liao Y; Zhu SH; Chen QC; Xie DM; Liao JJ; Feng X; Jiang MH; He W
Stem Cell Res Ther; 2019 Apr; 10(1):127. PubMed ID: 31029167
[TBL] [Abstract][Full Text] [Related]
18. Migration of marrow stromal cells in response to sustained release of stromal-derived factor-1alpha from poly(lactide ethylene oxide fumarate) hydrogels.
He X; Ma J; Jabbari E
Int J Pharm; 2010 May; 390(2):107-16. PubMed ID: 20219655
[TBL] [Abstract][Full Text] [Related]
19. Sustained release of basic fibroblast growth factor using gelatin hydrogel improved left ventricular function through the alteration of collagen subtype in a rat chronic myocardial infarction model.
Li Z; Masumoto H; Jo JI; Yamazaki K; Ikeda T; Tabata Y; Minatoya K
Gen Thorac Cardiovasc Surg; 2018 Nov; 66(11):641-647. PubMed ID: 29982930
[TBL] [Abstract][Full Text] [Related]
20. Intramyocardial delivery of VEGF165 via a novel biodegradable hydrogel induces angiogenesis and improves cardiac function after rat myocardial infarction.
Zhu H; Jiang X; Li X; Hu M; Wan W; Wen Y; He Y; Zheng X
Heart Vessels; 2016 Jun; 31(6):963-75. PubMed ID: 26142379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
